Access to medicines protestors target EU-India summit
This article was originally published in Scrip
The humanitarian body Médecins Sans Frontières (MSF) staged a protest outside the EU-India summit held at the European Commission HQ in Brussels involving about 100 demonstrators, on 10 December against the proposed EU-India free trade agreement fearing it will hinder access to affordable generic medicines in both India and in developing countries.The summit also saw media speculation that India may bilaterally resolve the EU generics seizure issue, while agency UNAIDS called on countries to ensure trade agreements do not affect access to HIV drugs
You may also be interested in...
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.